Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$5.68 USD
+0.02 (0.35%)
Updated May 7, 2024 04:00 PM ET
After-Market: $5.68 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: BMO |
3/2024 | $-0.63 | -40.28% |
Earnings Summary
For their last quarter, Editas Medicine (EDIT) reported earnings of -$0.23 per share, beating the Zacks Consensus Estimate of $-0.52 per share. This reflects a positive earnings surprise of 55.77%. Look out for EDIT's next earnings release on May 08, 2024. For the next earning release, we expect the company to report earnings of -$0.63 per share, reflecting a year-over-year increase of 11.27%.
Earnings History
Price & Consensus
Zacks News for EDIT
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
EDIT: What are Zacks experts saying now?
Zacks Private Portfolio Services